{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:43:15Z","timestamp":1780609395492,"version":"3.54.1"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.micpath.2024.106749","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T12:49:03Z","timestamp":1718282943000},"page":"106749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Engineered ClearColi\u2122-derived outer membrane vesicles as functional carriers for development of HIV-1 therapeutic vaccine candidate"],"prefix":"10.1016","volume":"193","author":[{"given":"Leila","family":"Sadeghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azam","family":"Bolhassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4653-7375","authenticated-orcid":false,"given":"Elham","family":"Mohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazem","family":"Baesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Aghasadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3587-2952","authenticated-orcid":false,"given":"Elnaz","family":"Agi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2024.106749_bib1","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0196-8858(81)90046-4","article-title":"Comparison of biosequences","volume":"2","author":"Smith","year":"1981","journal-title":"Adv. Appl. Math."},{"key":"10.1016\/j.micpath.2024.106749_bib2","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3390\/ijms24021563","article-title":"A CRISPR-cas cure for HIV\/AIDS","volume":"24","author":"Hussein","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2024.106749_bib3","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3390\/vaccines11020286","article-title":"The combination of an mRNA immunogen, a TLR7 agonist and a PD1 blocking agent enhances in-vitro HIV T-cell immune responses","volume":"11","author":"Usero","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.micpath.2024.106749_bib4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/14760584.2020.1712199","article-title":"HIV therapeutic vaccines aimed at intensifying combination antiretroviral therapy","volume":"19","author":"Moretti","year":"2020","journal-title":"Expet Rev. Vaccine"},{"key":"10.1016\/j.micpath.2024.106749_bib5","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1080\/21645515.2016.1276138","article-title":"Progress in HIV vaccine development","volume":"13","author":"Hsu","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.micpath.2024.106749_bib6","first-page":"313","volume":"15","author":"Li","year":"2016"},{"key":"10.1016\/j.micpath.2024.106749_bib7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10529-020-03060-3","article-title":"In vivo delivery of a multiepitope peptide and Nef protein using novel cell-penetrating peptides for development of HIV-1 vaccine candidate","volume":"43","author":"Davoodi","year":"2021","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.micpath.2024.106749_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1517\/14728214.12.1.23","article-title":"Problems and emerging approaches in HIV\/AIDS vaccine development","volume":"12","author":"Titti","year":"2007","journal-title":"Expet Opin. Emerg. Drugs"},{"key":"10.1016\/j.micpath.2024.106749_bib9","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1097\/QAD.0b013e3280112cd1","article-title":"Candidate HIV-1 Tat vaccine development: from basic science to clinical trials","volume":"20","author":"Ensoli","year":"2006","journal-title":"Aids"},{"key":"10.1016\/j.micpath.2024.106749_bib10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/08830180903013026","article-title":"HIV-1 Tat-based vaccines: an overview and perspectives in the field of HIV\/AIDS vaccine development","volume":"28","author":"Caputo","year":"2009","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.micpath.2024.106749_bib11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4049\/jimmunol.168.1.197","article-title":"Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses","volume":"168","author":"Fanales-Belasio","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2024.106749_bib12","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.3390\/ijms21114138","article-title":"Optimized conjugation of fluvastatin to hiv-1 tat displays enhanced pro-apoptotic activity in hepg2 cells","volume":"21","author":"Al-Wahaibi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2024.106749_bib13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2018.06.023","article-title":"Cell penetrating peptides in ocular drug delivery: state of the art","volume":"284","author":"Pescina","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.micpath.2024.106749_bib14","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3389\/fmicb.2018.00783","article-title":"Outer membrane vesicles: current status and future direction of these novel vaccine adjuvants","volume":"9","author":"Tan","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2024.106749_bib15","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1016\/j.vaccine.2009.03.040","article-title":"Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1\/Th2 bias in the immune response and protection against infection","volume":"27","author":"Mann","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2024.106749_bib16","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00203-022-03287-w","article-title":"The effects of different thermal and chemical stresses on release of outer membrane vesicles (OMVs) by ClearColi","volume":"204","author":"Hosseini Zadeh","year":"2022","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.micpath.2024.106749_bib17","first-page":"1","article-title":"Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection","volume":"6","author":"Huang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2024.106749_bib18","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/QCO.0000000000000606","article-title":"Neisseria meningitidis and meningococcal disease: recent discoveries and innovations","volume":"32","author":"Read","year":"2019","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.micpath.2024.106749_bib19","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.3389\/fmicb.2022.1029146","article-title":"Outer membrane vesicles: a bacterial-derived vaccination system","volume":"13","author":"Lieberman","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2024.106749_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.629090","article-title":"Outer membrane vesicle induction and isolation for vaccine development","volume":"12","author":"Balhuizen","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2024.106749_bib21","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1007\/s00284-021-02414-y","article-title":"The effect of growth stage and isolation method on properties of ClearColi\u2122 outer membrane vesicles (OMVs)","volume":"78","author":"Sharif","year":"2021","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.micpath.2024.106749_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/bit.27965","article-title":"Outer membrane vesicles (OMVs) enabled bio\u2010applications: a critical review","volume":"119","author":"Huang","year":"2022","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.micpath.2024.106749_bib23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/toxins14020078","article-title":"Cytolysin A (ClyA): a bacterial virulence factor with potential applications in nanopore technology, vaccine development, and tumor therapy","volume":"14","author":"Murase","year":"2022","journal-title":"Toxins"},{"key":"10.1016\/j.micpath.2024.106749_bib24","article-title":"Outer membrane vesicles for vaccination and targeted drug delivery","volume":"11","author":"Wang","year":"2019","journal-title":"Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology"},{"key":"10.1016\/j.micpath.2024.106749_bib25","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1073\/pnas.0805532107","article-title":"Delivery of foreign antigens by engineered outer membrane vesicle vaccines","volume":"107","author":"Chen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.micpath.2024.106749_bib26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/biology10020094","article-title":"Promising extracellular vesicle-based vaccines against viruses, including SARS-CoV-2","volume":"10","author":"Sabanovic","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.micpath.2024.106749_bib27","doi-asserted-by":"crossref","first-page":"698","DOI":"10.2174\/1567201814666171129210654","article-title":"Antiviral effects of saffron and its major ingredients","volume":"15","author":"Soleymani","year":"2018","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.micpath.2024.106749_bib28","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s11033-021-06727-w","article-title":"Different strategies for expression and purification of the CT26-poly-neoepitopes vaccine in Escherichia coli","volume":"49","author":"Movahed","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.micpath.2024.106749_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.29252\/JoMMID.7.1.2.37","article-title":"Enhancing HIV-1 Nef penetration into mammalian cells as an antigen candidate","volume":"7","author":"Davoodi","year":"2019","journal-title":"Journal of Medical Microbiology and Infectious Diseases"},{"key":"10.1016\/j.micpath.2024.106749_bib30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.imlet.2017.09.005","article-title":"Small heat shock protein 27: an effective adjuvant for enhancement of HIV-1 Nef antigen-specific immunity","volume":"191","author":"Milani","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.micpath.2024.106749_bib31","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1016\/j.vaccine.2008.03.082","article-title":"Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies","volume":"26","author":"Bolhassani","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2024.106749_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109406","article-title":"Different dendritic cells-based vaccine constructs influence HIV-1 antigen-specific immunological responses and cytokine generation in virion-exposed splenocytes","volume":"113","author":"Milani","year":"2022","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.micpath.2024.106749_bib33","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1039\/C7CC04246A","article-title":"Engineering multi-functional bacterial outer membrane vesicles as modular nanodevices for biosensing and bioimaging","volume":"53","author":"Chen","year":"2017","journal-title":"Chem. Commun."},{"key":"10.1016\/j.micpath.2024.106749_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-1759(03)00073-5","article-title":"A novel cytotoxicity assay to evaluate antigen-specific CTL responses using a colorimetric substrate for Granzyme B","volume":"276","author":"Ewen","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.micpath.2024.106749_bib35","volume":"118","author":"V\u00e1zquez","year":"2023"},{"key":"10.1016\/j.micpath.2024.106749_bib36","series-title":"Outer Membrane Vesicle Vaccines, Seminars in Immunology","author":"Micoli","year":"2020"},{"key":"10.1016\/j.micpath.2024.106749_bib37","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1080\/21645515.2017.1381810","article-title":"Impact of meningococcal group B OMV vaccines, beyond their brief","volume":"14","author":"Petousis-Harris","year":"2018","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.micpath.2024.106749_bib38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/MMBR.00031-09","article-title":"Virulence and immunomodulatory roles of bacterial outer membrane vesicles","volume":"74","author":"Ellis","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.micpath.2024.106749_bib39","first-page":"212","article-title":"Evaluation of antibody responses to outer membrane vesicles (OMVs) and killed whole cell of Vibrio cholerae O1 El Tor in immunized mice","volume":"11","author":"Sedaghat","year":"2019","journal-title":"Iran. J. Microbiol."},{"key":"10.1016\/j.micpath.2024.106749_bib40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00430-019-00583-z","article-title":"Genetic variation and function of the HIV-1 Tat protein","volume":"208","author":"Spector","year":"2019","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.micpath.2024.106749_bib41","doi-asserted-by":"crossref","first-page":"452","DOI":"10.36233\/0507-4088-83","article-title":"Analysis of Tat protein characteristics in human immunodeficiency virus type 1 sub-subtype A6 (Retroviridae: orthoretrovirinae: Lentivirus: human immunodeficiency virus-1)","volume":"66","author":"Kuznetsova","year":"2021","journal-title":"Prob. Virol."},{"key":"10.1016\/j.micpath.2024.106749_bib42","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2174\/1570162043350986","article-title":"Recent advances in the development of HIV-1 Tat-based vaccines","volume":"2","author":"Caputo","year":"2004","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.micpath.2024.106749_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25793","article-title":"Current approaches to HIV vaccine development: a narrative review","volume":"24","author":"Kim","year":"2021","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.micpath.2024.106749_bib44","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.vaccine.2005.08.007","article-title":"Progress towards an HIV-1 subtype C vaccine","volume":"24","author":"Nkolola","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2024.106749_bib45","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1128\/JVI.77.2.1049-1058.2003","article-title":"Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccine","volume":"77","author":"Voss","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2024.106749_bib46","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jbiotec.2019.09.012","article-title":"On the expression of recombinant Cas9 protein in E. coli BL21 (DE3) and BL21 (DE3) Rosetta strains","volume":"306","author":"Carmignotto","year":"2019","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.micpath.2024.106749_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202300402","article-title":"Investigation of immunostimulatory effects of IFN\u2010\u03b3 cytokine and CD40 ligand costimulatory molecule for development of HIV\u20101 therapeutic vaccine candidate","volume":"8","author":"Heidarnejad","year":"2024","journal-title":"Advanced Biology"},{"key":"10.1016\/j.micpath.2024.106749_bib48","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2174\/0929866530666230403093538","article-title":"Comparison of adjuvant effects of Montanide ISA-720 and heat shock protein 27 in increasing immunostimulatory properties of HIV-1 Nef-Vif fusion protein construct","volume":"30","author":"Khairkhah","year":"2023","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.micpath.2024.106749_bib49","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.pep.2009.08.017","article-title":"Increased levels of recombinant human proteins with the Escherichia coli strain Rosetta (DE3)","volume":"69","author":"Tegel","year":"2010","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.micpath.2024.106749_bib50","series-title":"Cloning, Expression and Purification of a Mutant Tomato Thymidine Kinase 1 for Crystallography","author":"Nesrini","year":"2015"},{"key":"10.1016\/j.micpath.2024.106749_bib51","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.tips.2017.06.002","article-title":"An overview of novel adjuvants designed for improving vaccine efficacy","volume":"38","author":"Bonam","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.micpath.2024.106749_bib52","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2191577","article-title":"Tracking the COVID-19 vaccines: the global landscape","volume":"19","author":"Yadav","year":"2023","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.micpath.2024.106749_bib53","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.vaccine.2022.02.029","article-title":"A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: safety, reactogenicity and immunogenicity","volume":"40","author":"P\u00e9rez-Rodr\u00edguez","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2024.106749_bib54","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri3837","article-title":"Immune modulation by bacterial outer membrane vesicles","volume":"15","author":"Kaparakis-Liaskos","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.micpath.2024.106749_bib55","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3390\/vaccines10101578","article-title":"Outer membrane vesicles: an emerging vaccine platform","volume":"10","author":"Kashyap","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.micpath.2024.106749_bib56","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1080\/21645515.2020.1825896","article-title":"Recent advances in vaccine and immunotherapy for COVID-19","volume":"16","author":"Rabaan","year":"2020","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.micpath.2024.106749_bib57","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1080\/21645515.2021.1920272","article-title":"Experimental studies using OMV in a new platform of SARS-CoV-2 vaccines","volume":"17","author":"Gaspar","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.micpath.2024.106749_bib58","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1128\/IAI.01139-08","article-title":"Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera","volume":"77","author":"Schild","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micpath.2024.106749_bib59","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00253-022-11758-9","article-title":"ClearColi as a platform for untagged pneumococcal surface protein A production: cultivation strategy, bioreactor culture, and purification","volume":"106","author":"Cardoso","year":"2022","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2024.106749_bib60","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1021\/acsomega.1c04549","article-title":"Outer membrane vesicles secreted by Helicobacter pylori transmitting gastric pathogenic virulence factors","volume":"7","author":"Wei","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.micpath.2024.106749_bib61","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1039\/D1CB00200G","article-title":"A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and Neisseria meningitidis outer membrane vesicles","volume":"3","author":"Santana-Mederos","year":"2022","journal-title":"RSC Chemical Biology"},{"key":"10.1016\/j.micpath.2024.106749_bib62","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fmats.2020.00202","article-title":"Engineered bacterial outer membrane vesicles as multifunctional delivery platforms","volume":"7","author":"Li","year":"2020","journal-title":"Frontiers in Materials"},{"key":"10.1016\/j.micpath.2024.106749_bib63","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jmb.2008.03.076","article-title":"Engineered bacterial outer membrane vesicles with enhanced functionality","volume":"380","author":"Kim","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.micpath.2024.106749_bib64","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.vaccine.2016.01.028","article-title":"Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB\/c mice","volume":"34","author":"Rappazzo","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2024.106749_bib65","series-title":"Endotoxin-free Protein Production\u2014ClearColi\u2122 Technology","author":"Mamat","year":"2013"},{"key":"10.1016\/j.micpath.2024.106749_bib66","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftac021","article-title":"Immunopotentiation by linking Hsp70 T-cell epitopes to Gag-Pol-Env-Nef-Rev multiepitope construct and increased IFN-gamma secretion in infected lymphocytes","volume":"80","author":"Akbari","year":"2022","journal-title":"Pathogens and Disease"},{"key":"10.1016\/j.micpath.2024.106749_bib67","series-title":"Study of Anti-retroviral Effects of Salix Aegyptiaca L Herbal Extract on HIV-1 In-Vitro","author":"Eftekhari","year":"2014"},{"key":"10.1016\/j.micpath.2024.106749_bib68","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/hiv.13576","article-title":"Immunostimulatory effects of Hsp70 fragments and Hsp27 in design of novel HIV\u20101 vaccine formulations","volume":"25","author":"Milani","year":"2024","journal-title":"HIV Med."},{"key":"10.1016\/j.micpath.2024.106749_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.132236","article-title":"Engineered dendritic cells-derived exosomes harboring HIV-1 Nefmut-Tat fusion protein and heat shock protein 70: a promising HIV-1 safe vaccine candidate","author":"Pordanjani","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.micpath.2024.106749_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.617516","article-title":"Advances in humanized mouse models to improve understanding of HIV-1 pathogenesis and immune responses","volume":"11","author":"Gillgrass","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2024.106749_bib71","series-title":"Experimental Animal Models of Human Diseases\u2014An Effective Therapeutic Strategy","first-page":"159","article-title":"Experimental animal models of HIV\/AIDS for vaccine trials","author":"Ibeh","year":"2018"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240102400216X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240102400216X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T18:43:25Z","timestamp":1721501005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088240102400216X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":71,"alternative-id":["S088240102400216X"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2024.106749","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered ClearColi\u2122-derived outer membrane vesicles as functional carriers for development of HIV-1 therapeutic vaccine candidate","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2024.106749","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106749"}}